<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / GlaxoSmithKline / Generic drug / Pfizer / Food and Drug Administration / Intas Biopharmaceuticals / Pharmaceutical sciences / Pharmacology / Health
Date: 2012-05-31 05:34:33
Pharmaceuticals policy
Pharmaceutical industry
Pharmacy
GlaxoSmithKline
Generic drug
Pfizer
Food and Drug Administration
Intas Biopharmaceuticals
Pharmaceutical sciences
Pharmacology
Health

Add to Reading List

Source URL: www.pronova.com

Download Document from Source Website

File Size: 4,67 MB

Share Document on Facebook

Similar Documents

CNX Nifty / Science and technology in Israel / Teva Pharmaceutical Industries / Mylan / Intas Biopharmaceuticals / Ranbaxy Laboratories / PVT

REGISTER FOR APPROVED HUMAN MEDICINES JUNE 2016 UPDATE GENERIC NAME FORM DEXTROSE MONOHYDRATE OR ANHYDROUS INFUSIONS

DocID: 1ppk7 - View Document

Biosimilar / Biotechnology / Drugs / Intas Biopharmaceuticals / Biologic / Pharmaceutical industry in India / Quintiles / Pharmaceutical industry / Pharmacy school / Pharmacology / Pharmaceutical sciences / Clinical research

Oct 27-29, 2014 Nigel Rulewski TENTATIVE SCIENTIFIC PROGRAM Eminent Speakers

DocID: HnQg - View Document

Pharmaceutical industry / Food and Drug Administration / Pharmaceuticals policy / Biosimilar / Intas Biopharmaceuticals / Biologic / Hospira / Clinical trial / Reliance Life Sciences / Pharmaceutical sciences / Pharmacology / Clinical research

Article Current regulations governing biosimilars

DocID: 25Gi - View Document

Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / GlaxoSmithKline / Generic drug / Pfizer / Food and Drug Administration / Intas Biopharmaceuticals / Pharmaceutical sciences / Pharmacology / Health

PDF Document

DocID: 1nuZ - View Document